主观认知下降与Tau蛋白沉积的区域特异性关联独立于全局β-淀粉样蛋白负荷
本研究纳入133名临床健康的老年参与者,通过PET成像测量β-淀粉样蛋白(Aβ)和Tau蛋白沉积,发现主观认知下降(SCD)与内嗅皮层Tau负担及全局Aβ负担相关,但与下颞叶Tau负担无关,且内嗅皮层Tau与SCD的关联在很大程度上独立于Aβ负担。
要点
- SCD与内嗅皮层Tau沉积独立相关,提示早期阿尔茨海默病病理。
- SCD也与全局Aβ负担相关,但关联强度较弱。
- 内嗅皮层Tau与Aβ对SCD的影响无交互作用。
核心结论
- 主观认知下降反映内嗅皮层早期Tau蛋白沉积,并与全局Aβ水平升高相关,两者可能通过独立通路影响SCD。
研究设计与样本
- 哈佛衰老脑研究的影像学子研究,纳入133名临床健康老年人(临床痴呆评定量表全局评分为0),进行横断面Flortaucipir F 18 PET测量Tau和Pittsburgh compound B PET测量Aβ。
主要发现
- 探索性全脑分析显示SCD主要与内嗅皮层Tau负担相关。
临床怎么用
- 在临床健康的老年人中评估SCD时,应考虑内嗅皮层Tau沉积和全局Aβ负担等多项生物学因素。
局限性
- 横断面设计无法确定因果关系。
- 样本为临床健康老年人,结果可能不适用于其他人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The ability to explore associations between reports of subjective cognitive decline (SCD) and biomarkers of early Alzheimer disease (AD) pathophysiologic processes (accumulation of neocortical β-amyloid [Aβ] and tau) provides an important opportunity to understand the basis of SCD and AD risk. OBJECTIVE: To examine associations between SCD and global Aβ and tau burdens in regions of interest in clinically healthy older adults. DESIGN, SETTING, AND PARTICIPANTS: This imaging substudy of the Harvard Aging Brain Study included 133 clinically healthy older participants (Clinical Dementia Rating Scale global scores of 0) participating in the Harvard Aging Brain Study who underwent cross-sectional flortaucipir F 18 (previously known as AV 1451, T807) positron emission tomography (FTP-PET) imaging for tau and Pittsburgh compound B carbon 11-labeled PET (PiB-PET) imaging for Aβ. The following 2 regions for tau burden were identified: the entorhinal cortex, which exhibits early signs of tauopathy, and the inferior temporal region, which is more closely associated with AD-related pathologic mechanisms. Data were collected from June 11, 2012, through April 7, 2016. MAIN OUTCOMES AND MEASURES: Subjective cognitive decline was measured using a previously published method of z-transforming subscales from the Memory Functioning Questionnaire, the Everyday Cognition battery, and a 7-item questionnaire. The Aβ level was measured according to a summary distribution volume ratio of frontal, lateral temporal and parietal, and retrosplenial PiB-PET tracer uptake. The FTP-PET measures were computed as standardized uptake value ratios. Linear regression models focused on main and interactive effects of Aβ, entorhinal cortical, and inferior temporal tau on SCD, controlling for age, sex, educational attainment, and Geriatric Depression Scale score. RESULTS: Of the 133 participants, 75 (56.3%) were women and 58 (43.6%) were men; mean (SD) age was 76 (6.9) years (range, 55-90 years). Thirty-nine participants (29.3%) exhibited a high Aβ burden. Greater SCD was associated with increasing entorhinal cortical tau burden (β = 0.35; 95% CI, 0.19-.52; P < .001) and Aβ burden (β = 0.24; 95% CI, 0.08-.40; P = .005), but not inferior temporal tau burden (β = 0.10; 95% CI, -0.08 to 0.28; P = .27). This association between entorhinal cortical tau burden and SCD was largely unchanged after accounting for Aβ burden (β = 0.36; 95% CI, 0.15-.58; P = .001), and no interaction influenced SCD (β = -0.36; 95% CI, -0.34 to 0.09; P = .25). An exploratory post hoc whole-brain analysis also indicated that SCD was predominantly associated with greater tau burden in the entorhinal cortex. CONCLUSIONS AND RELEVANCE: Subjective cognitive decline is indicative of accumulation of early tauopathy in the medial temporal lobe, specifically in the entorhinal cortex, and to a lesser extent, elevated global levels of Aβ. Our findings suggest multiple underlying pathways that motivate SCD that do not necessarily interact to influence SCD endorsement. As such, multiple biological factors must be considered when assessing SCD in clinically healthy older adults.
引用
- Buckley RF, Hanseeuw B, Schultz AP, et al. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. JAMA Neurol. 2017. PMID: 28973551. doi:10.1001/jamaneurol.2017.2216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。